Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Plus Therapeutics Inc
PSTVCurrent price
1.14 USD
+0.07 USD (+6.54%)
Last closed
1.18 USD
Company
www.plustherapeutics.com
ISIN
US72941H4002
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
6 898 706 USD
Yield for 12 month
-40.63 %
1Y
3Y
5Y
10Y
15Y
PSTV
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas. Address: 4200 Marathon Boulevard, Austin, TX, United States, 78756
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.75 USDP/E ratio
–Dividend Yield
–Current Year
+4 913 000 USD
Last Year
+224 000 USD
Current Quarter
–
Last Quarter
+1 279 000 USD
Current Year
-4 777 000 USD
Last Year
-488 000 USD
Current Quarter
–
Last Quarter
-1 494 000 USD
Key Figures PSTV
1 year
3 years
5 years
10 years
EBITDA
-13 470 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-69.39 %
PEG Ratio
–
Return On Equity TTM
-522.50 %
Wall Street Target Price
15.75 USD
Revenue TTM
5 509 000 USD
Book Value
-0.30 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-31.00 %
Dividend Yield
–
Gross Profit TTM
-9 474 000 USD
Earnings per share
-2.37 USD
Diluted Eps TTM
-2.37 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-240.15 %
Dividend Analytics PSTV
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History PSTV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
01.05.2023
Stock Valuation PSTV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
18.19
Price Sales TTM
1.25
Enterprise Value EBITDA
-0.30
Price Book MRQ
3.76
Financials PSTV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PSTV
For 52 weeks
1.03 USD
2.67 USD
50 Day MA
1.32 USD
Shares Short Prior Month
103 977
200 Day MA
1.66 USD
Short Ratio
0.98
Shares Short
113 964
Short Percent
0.90 %
BeatStart